Peyrl A - Search Results

1

Awake brain surgery for language mapping in pediatric patients: a single-center experience.

Herta J, Winter F, Pataraia E, Feucht M, Czech T, Porsche B, Leiss U, Slavc I, Peyrl A, Kasprian G, Rössler K, Dorfer C. Herta J, et al. Among authors: peyrl a. J Neurosurg Pediatr. 2022 Mar 11;29(6):700-710. doi: 10.3171/2022.1.PEDS21569. Print 2022 Jun 1. J Neurosurg Pediatr. 2022. PMID: 35276657

2

A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors.

Taubenschmid-Stowers J, Orthofer M, Laemmerer A, Krauditsch C, Rózsová M, Studer C, Lötsch D, Gojo J, Gabler L, Dyczynski M, Efferth T, Hagelkruys A, Widhalm G, Peyrl A, Spiegl-Kreinecker S, Hoepfner D, Bian S, Berger W, Knoblich JA, Elling U, Horn M, Penninger JM. Taubenschmid-Stowers J, et al. Among authors: peyrl a. EMBO Mol Med. 2023 Mar 8;15(3):e16959. doi: 10.15252/emmm.202216959. Epub 2023 Feb 6. EMBO Mol Med. 2023. PMID: 36740985 Free PMC article.

3

Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles.

Peyrl A, Krapfenbauer K, Slavc I, Yang JW, Strobel T, Lubec G. Peyrl A, et al. Proteomics. 2003 Sep;3(9):1781-800. doi: 10.1002/pmic.200300460. Proteomics. 2003. PMID: 12973738

4

Proteomic characterization of the human cortical neuronal cell line HCN-2.

Peyrl A, Krapfenbauer K, Slavc I, Strobel T, Lubec G. Peyrl A, et al. J Chem Neuroanat. 2003 Nov;26(3):171-8. doi: 10.1016/s0891-0618(03)00079-6. J Chem Neuroanat. 2003. PMID: 14615026

5

Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.

Peyrl A, Azizi A, Czech T, Gruber-Olipitz M, Jones N, Haberler C, Prayer D, Autzinger E, Slavc I. Peyrl A, et al. Pediatr Blood Cancer. 2009 Apr;52(4):476-80. doi: 10.1002/pbc.21881. Pediatr Blood Cancer. 2009. PMID: 19061223 Clinical Trial.

6

Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.

Peyrl A, Sauermann R, Traunmueller F, Azizi AA, Gruber-Olipitz M, Gupper A, Slavc I. Peyrl A, et al. Clin Pharmacokinet. 2009;48(4):265-71. doi: 10.2165/00003088-200948040-00004. Clin Pharmacokinet. 2009. PMID: 19492871

7

Feasibility and tolerability of bevacizumab in children with primary CNS tumors.

Reismüller B, Azizi AA, Peyrl A, Heinrich M, Gruber-Olipitz M, Luckner D, Rothschild KV, Slavc I. Reismüller B, et al. Among authors: peyrl a. Pediatr Blood Cancer. 2010 May;54(5):681-6. doi: 10.1002/pbc.22409. Pediatr Blood Cancer. 2010. PMID: 20066713

8

Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.

Peyrl A, Chocholous M, Kieran MW, Azizi AA, Prucker C, Czech T, Dieckmann K, Schmook MT, Haberler C, Leiss U, Slavc I. Peyrl A, et al. Pediatr Blood Cancer. 2012 Sep;59(3):511-7. doi: 10.1002/pbc.24006. Epub 2011 Dec 6. Pediatr Blood Cancer. 2012. PMID: 22147459

9

Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing.

Peyrl A, Sauermann R, Chocholous M, Azizi AA, Jäger W, Höferl M, Slavc I. Peyrl A, et al. Clin Pharmacokinet. 2014 Feb;53(2):165-73. doi: 10.1007/s40262-013-0106-1. Clin Pharmacokinet. 2014. PMID: 24129691 Clinical Trial.

10

Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.

Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA, Dieckmann K, Woehrer A, Peters C, Widhalm G, Dorfer C, Czech T. Slavc I, et al. Among authors: peyrl a. Cancer Med. 2014 Feb;3(1):91-100. doi: 10.1002/cam4.161. Epub 2013 Dec 11. Cancer Med. 2014. PMID: 24402832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page